Developer docs
API playgroundTry for free, no card

Search company profiles

CalmiGo

Full company profile

uuid00028hc

Namestring
CalmiGo
Legal namestring
CalmiGo
Websiteurl
calmigo.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

CalmiGo is a New York-based private health technology company founded in 2016 that designs, manufactures, and sells a patented, FDA-cleared handheld device (the CalmiGo Exhaler) delivering drug-free relief for anxiety, panic attacks, PTSD, and stress. The device combines three techniques — personalized breathing regulation, multi-sensory stimulation (visual, olfactory, tactile, and auditory), and calming scents delivered via solidified pure-oil plates — to activate the parasympathetic nervous system and reduce stress hormones. The product is suitable for users aged 6 and up, is suitable for acute and long-term use, and is supported by 8 independent clinical studies reporting significant improvements across anxiety (88.9%), chronic stress (100%), work stress (90.9%), well-being (95.2%), sleep quality (73.8%), and PTSD (89.5%); a companion app and consumable scented plates supplement the core device.

The company monetizes primarily through one-time sales of the device, with repeat revenue potential from scented-plate consumables. CalmiGo distributes via direct-to-consumer e-commerce on calmigo.com, the FSA Store for tax-advantaged purchases, VA Clinics and the Military Health System (MHS) for military and veteran populations, and select health plans. Its go-to-market blends owned digital channels and content, earned media (Forbes, Yahoo, MSN), clinician referral pathways, and payer partnerships; press and awards (CES Innovation Award 2025, Parents' Picks, Mom's Choice) support consumer credibility. Primary customers are individual consumers experiencing anxiety or stress; secondary stakeholders include clinicians, health plans, and military/veteran populations.

Short descriptiontext

CalmiGo is a New York-based health technology company that sells a patented, FDA-cleared, drug-free handheld device providing immediate relief from anxiety, panic attacks, PTSD, and stress via breathing regulation and multi-sensory stimulation. It distributes through DTC e-commerce, the FSA Store, VA Clinics, the Military Health System, and health plans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
drug-free anxiety device, breathing regulation technology, mental health medical device, stress relief handheld device, PTSD calming solution
Industry2 codes
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHSADAJAC
Breathwork Facilitation (Pranayama, Somatic, Holotropic-style)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Consumer Mental Health Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Device Sales
TypeOne Time License
Description

Sale of the CalmiGo patented device providing immediate drug-free relief for anxiety, panic attacks, PTSD, and stress. Suitable for ages 6 and up.

calmigo.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CalmiGo sells a patented, FDA-cleared handheld medical device (the Exhaler) that provides immediate drug-free relief from anxiety, panic attacks, PTSD, and stress. The device combines personalized breathing regulation, multi-sensory stimulation (visual lights, calming scent, vibration, sound), and solidified pure-oil scents to activate the parasympathetic nervous system. Suitable for ages 6 and up, with 8 independent clinical studies validating efficacy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 88.9% improvement in Anxiety (clinical study)
+6 more records
Product overview1 text field

CalmiGo is a health technology company offering a single core product: the CalmiGo Device (also called the Exhaler). The device is a patented, handheld tool that provides immediate drug-free relief for anxiety, panic attacks, PTSD, and stress. The product uses three integrated techniques—personalized breathing regulation, multi-sensory stimulation (visual, olfactory, tactile, auditory), and calming essential oil scents—to activate the parasympathetic nervous system. CalmiGo offers a companion app to enhance relaxation and build resilience, along with scented plates as consumable accessories. The product is covered by FSA and VA/MHS insurance programs.

Product and service1 record
1CalmiGo Device (Exhaler)
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CalmiGo is available for purchase through FSA Store, allowing customers to use their Flexible Spending Account funds for the device, making it more accessible for consumers with FSA coverage.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CalmiGo is covered through the Military Health System, providing access to active duty military personnel and their families for anxiety and stress management.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Apollo Neuro
TypeDirect peer
Description

Apollo Neuro sells a wearable device that uses gentle vibrations to shift the nervous system from sympathetic to parasympathetic, directly competing with CalmiGo on drug-free, multi-sensory stress and anxiety relief.

2TouchPoint Solution
TypeDirect peer
Description

TouchPoint Solution produces a wearable device that delivers micro-pulses to reduce stress and anxiety, making it a close functional peer to CalmiGo's multi-sensory, drug-free Exhaler.

TypeDirect peer
Description

Muse offers a brain-sensing headband and app for meditation and stress management, competing in the same consumer mental-wellness device category as CalmiGo with biofeedback-led positioning.

4Spire Health
TypeDirect peer
Description

Spire makes wearable breath and stress trackers that aim to reduce anxiety through continuous physiological monitoring, overlapping with CalmiGo's breath-regulation-based anxiety approach.

5Calm
TypeEmerging player
Description

Calm is a leading meditation and sleep app with guided breathing exercises targeting anxiety and stress — competing with CalmiGo for the same anxious consumer but delivering through a software subscription rather than a hardware device.

TypeEmerging player
Description

Headspace offers guided meditation, sleep, and focus content including breathwork exercises, providing a lower-cost, software-based alternative to CalmiGo's hardware for stress and anxiety relief.

TypeBroad incumbent
Description

WHOOP is a wearable health platform with stress and recovery metrics powered by continuous biometric monitoring, competing in the broader stress-management wearables category rather than CalmiGo's handheld acute-relief niche.

TypeBroad incumbent
Description

Garmin offers smartwatches with built-in stress tracking, breathwork modes, and sleep monitoring — a broad incumbent with overlapping consumer stress-management functionality, though not specialized in acute anxiety relief like CalmiGo.

TypeBroad incumbent
Description

Fitbit devices and the Fitbit app include stress management scores, guided breathing, and sleep tracking, positioning Google/Fitbit as a broad incumbent alternative to dedicated anxiety devices like CalmiGo.

10Reflect
TypeEmerging player
Description

Reflect is an emerging breathwork and mindfulness device company that, like CalmiGo, targets consumers seeking device-based, multi-sensory tools for anxiety and stress reduction.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CalmiGo

Consumer Mental Health Medical Devicescalmigo.com

CalmiGo is a New York-based health technology company that sells a patented, FDA-cleared, drug-free handheld device providing immediate relief from anxiety, panic attacks, PTSD, and stress via breathing regulation and multi-sensory stimulation. It distributes through DTC e-commerce, the FSA Store, VA Clinics, the Military Health System, and health plans.

What CalmiGo does

CalmiGo is a New York-based private health technology company founded in 2016 that designs, manufactures, and sells a patented, FDA-cleared handheld device (the CalmiGo Exhaler) delivering drug-free relief for anxiety, panic attacks, PTSD, and stress. The device combines three techniques — personalized breathing regulation, multi-sensory stimulation (visual, olfactory, tactile, and auditory), and calming scents delivered via solidified pure-oil plates — to activate the parasympathetic nervous system and reduce stress hormones. The product is suitable for users aged 6 and up, is suitable for acute and long-term use, and is supported by 8 independent clinical studies reporting significant improvements across anxiety (88.9%), chronic stress (100%), work stress (90.9%), well-being (95.2%), sleep quality (73.8%), and PTSD (89.5%); a companion app and consumable scented plates supplement the core device.

The company monetizes primarily through one-time sales of the device, with repeat revenue potential from scented-plate consumables. CalmiGo distributes via direct-to-consumer e-commerce on calmigo.com, the FSA Store for tax-advantaged purchases, VA Clinics and the Military Health System (MHS) for military and veteran populations, and select health plans. Its go-to-market blends owned digital channels and content, earned media (Forbes, Yahoo, MSN), clinician referral pathways, and payer partnerships; press and awards (CES Innovation Award 2025, Parents' Picks, Mom's Choice) support consumer credibility. Primary customers are individual consumers experiencing anxiety or stress; secondary stakeholders include clinicians, health plans, and military/veteran populations.

CalmiGo firmographics

Firmographics
Name
CalmiGo
Legal name
CalmiGo
Website
https://calmigo.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
CalmiGo is a New York-based health technology company that sells a patented, FDA-cleared, drug-free handheld device providing immediate relief from anxiety, panic attacks, PTSD, and stress via breathing regulation and multi-sensory stimulation. It distributes through DTC e-commerce, the FSA Store, VA Clinics, the Military Health System, and health plans.
Ownership category
akta.pro rank

CalmiGo industry classification

Industry
Product category
Consumer Mental Health Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHSADAJAC
Breathwork Facilitation (Pranayama, Somatic, Holotropic-style)

Keywords

  • Drug-free anxiety device
  • Breathing regulation technology
  • Mental health medical device
  • Stress relief handheld device
  • PTSD calming solution

Where CalmiGo is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

CalmiGo business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations

Revenue model

  1. Device Sales: Sale of the CalmiGo patented device providing immediate drug-free relief for anxiety, panic attacks, PTSD, and stress. Suitable for ages 6 and up.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

CalmiGo product offering

Product offering

Core offering

CalmiGo sells a patented, FDA-cleared handheld medical device (the Exhaler) that provides immediate drug-free relief from anxiety, panic attacks, PTSD, and stress. The device combines personalized breathing regulation, multi-sensory stimulation (visual lights, calming scent, vibration, sound), and solidified pure-oil scents to activate the parasympathetic nervous system. Suitable for ages 6 and up, with 8 independent clinical studies validating efficacy.

Product overview

CalmiGo is a health technology company offering a single core product: the CalmiGo Device (also called the Exhaler). The device is a patented, handheld tool that provides immediate drug-free relief for anxiety, panic attacks, PTSD, and stress. The product uses three integrated techniques—personalized breathing regulation, multi-sensory stimulation (visual, olfactory, tactile, auditory), and calming essential oil scents—to activate the parasympathetic nervous system. CalmiGo offers a companion app to enhance relaxation and build resilience, along with scented plates as consumable accessories. The product is covered by FSA and VA/MHS insurance programs.

Differentiator

Problem solved

Functional benefit

Products and services

  • CalmiGo Device (Exhaler)

Quantifiable outcome

  • 88.9% improvement in Anxiety (clinical study)
  • +6 more outcomes

Companies that use CalmiGo

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

CalmiGo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

CalmiGo partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • FSA StorecoreChannel Partner/ Reseller/ DistributorCalmiGo is available for purchase through FSA Store, allowing customers to use their Flexible Spending Account funds for the device, making it more accessible for consumers with FSA coverage.
  • MHS (Military Health System)coreChannel Partner/ Reseller/ DistributorCalmiGo is covered through the Military Health System, providing access to active duty military personnel and their families for anxiety and stress management.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

CalmiGo competitors and assessment

Company assessment

Direct peers

  • Apollo Neuro: Apollo Neuro sells a wearable device that uses gentle vibrations to shift the nervous system from sympathetic to parasympathetic, directly competing with CalmiGo on drug-free, multi-sensory stress and anxiety relief.
  • TouchPoint Solution: TouchPoint Solution produces a wearable device that delivers micro-pulses to reduce stress and anxiety, making it a close functional peer to CalmiGo's multi-sensory, drug-free Exhaler.
  • Muse: Muse offers a brain-sensing headband and app for meditation and stress management, competing in the same consumer mental-wellness device category as CalmiGo with biofeedback-led positioning.
  • Spire Health: Spire makes wearable breath and stress trackers that aim to reduce anxiety through continuous physiological monitoring, overlapping with CalmiGo's breath-regulation-based anxiety approach.

Emerging players

  • Calm: Calm is a leading meditation and sleep app with guided breathing exercises targeting anxiety and stress — competing with CalmiGo for the same anxious consumer but delivering through a software subscription rather than a hardware device.
  • Headspace: Headspace offers guided meditation, sleep, and focus content including breathwork exercises, providing a lower-cost, software-based alternative to CalmiGo's hardware for stress and anxiety relief.
  • Reflect: Reflect is an emerging breathwork and mindfulness device company that, like CalmiGo, targets consumers seeking device-based, multi-sensory tools for anxiety and stress reduction.

Broad incumbents

  • WHOOP: WHOOP is a wearable health platform with stress and recovery metrics powered by continuous biometric monitoring, competing in the broader stress-management wearables category rather than CalmiGo's handheld acute-relief niche.
  • Garmin: Garmin offers smartwatches with built-in stress tracking, breathwork modes, and sleep monitoring — a broad incumbent with overlapping consumer stress-management functionality, though not specialized in acute anxiety relief like CalmiGo.
  • Fitbit (Google): Fitbit devices and the Fitbit app include stress management scores, guided breathing, and sleep tracking, positioning Google/Fitbit as a broad incumbent alternative to dedicated anxiety devices like CalmiGo.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CalmiGo social profiles

Digital presence

CalmiGo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CalmiGo leadership team

Management profile

Number of profiles

Profiles3 records

CalmiGo funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CalmiGo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CalmiGo

What does CalmiGo do?

CalmiGo sells a patented, FDA-cleared handheld medical device (the Exhaler) that provides immediate drug-free relief from anxiety, panic attacks, PTSD, and stress. The device combines personalized breathing regulation, multi-sensory stimulation (visual lights, calming scent, vibration, sound), and solidified pure-oil scents to activate the parasympathetic nervous system. Suitable for ages 6 and up, with 8 independent clinical studies validating efficacy.

Is CalmiGo a public or private company?

CalmiGo is a private company. It is classified as venture growth investor backed and is currently operating.

When was CalmiGo founded?

CalmiGo was founded in 2016. It employs 11 to 50 people.

Where is CalmiGo based?

CalmiGo is headquartered in New York, United States, in the North America region.

How does CalmiGo make money?

One revenue line is on record: device Sales.

Who are CalmiGo's main competitors?

Direct peers on record are Apollo Neuro, TouchPoint Solution, Muse and Spire Health. Emerging players are Calm, Headspace and Reflect. Broad incumbents are WHOOP, Garmin and Fitbit (Google).

Does CalmiGo have an API?

No public API is recorded for CalmiGo.

What industry is CalmiGo in?

CalmiGo's product category is Consumer Mental Health Medical Devices. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices), with a secondary code of HSADAJAC, Breathwork Facilitation (Pranayama, Somatic, Holotropic-style). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebCalmiGo Expands Workplace Mental Health Benefits with JOON PartnershipCalmiGo has entered a partnership with JOON, a flexible employee benefits platform, to expand access to its mental health technology for workplace use. Through this collaboration, employers utilizing JOON can now reimburse employees for CalmiGo, integrating the device into broader wellness and lifestyle spending accounts. This move aims to address workplace burnout by providing an evidence-based solution for anxiety and stress management.EIN PresswireHow Competition Is Evolving in the Panic Attack Treatment MarketThe panic attack treatment market is dominated by global pharmaceutical companies, with Pfizer leading 2024 sales at a 3% market share. The top 10 players held 19% of total revenue in 2024, reflecting a fragmented market with moderate entry barriers. Digital anxiety relief platforms and AI-driven monitoring are emerging competitive trends.Taipei TimesCES to showcase mental health support technologyCES in Las Vegas will showcase mental health support technology, including Nutrix's cortiSense cortisol sensor, Baracoda's BMind smart mirror, and CalmiGo panic device. The devices aim to monitor stress, detect fatigue, and calm users, with some already sold in the US. A psychologist expressed skepticism about robots addressing underlying anxiety.Digital TrendsPeople don’t trust tech. CES 2025 is a chance to change thatThe author argues that public trust in technology has dramatically declined since 2007, citing YouGov surveys showing Facebook, Amazon, and Google as the companies with the steepest drops in institutional trust, and noting that 79% of tech professionals do not trust Big Tech on AI. Kinsey Fabrizio, the new president of the Consumer Technology Association (which runs CES), contends that the trade show is evolving to showcase 'Tech for Good' solutions addressing global challenges like water scarcity, healthcare access, and sustainability. The article suggests CES 2025 offers a mix of consumer novelty and substantive problem-solving innovations, including companies like AirFarm, CalmiGo Plus, and DisMantleBot that address food security, mental health, and EV battery recycling respectively.Business Wire BlogCalmiGo Named as CES Innovation Awards® 2025 HonoreeCalmiGo was named a CES Innovation Awards 2025 Honoree in the digital health category for its CalmiGo Plus product. The CES program received over 3,400 submissions, and the award recognizes the company's combination of physiological and psychological methods with gaming technology to manage anxiety.YahooCalmiGo Launches Next Generation Healthcare Platform, CalmiGo Plus, for Users to Manage Anxiety and Track Data InsightsCalmiGo launched CalmiGo Plus, a next-generation platform combining its device and a new app to manage anxiety. The app uses gaming technology and tracks progress, with over 100,000 users benefiting from the device. The company also expanded access via payment plans and partnerships, including with the U.S. Department of Veterans Affairs.PR NewswireCalmiGo, On-the-spot Aid For Anxiety, Is Now Available At Select CVS Health Stores NationwideCalmiGo, a patented drug-free portable device for anxiety relief, has expanded its retail presence to 800 CVS Health stores nationwide, in addition to existing sales on Amazon.com and its own website. The device regulates breathing patterns and uses multisensory stimulation to restore calm within three minutes by activating the parasympathetic nervous system. Mayo Clinic and Northwell Health (Lenox Hill) are currently conducting clinical studies on the device, which has sold over 40,000 units since its 2020 launch.TechRepublic13 meditation apps and self-care products to relieve stressThe article lists meditation apps and self-care products to relieve stress, citing that 55% of US employees experience burnout. It includes Headspace, Insight Timer, Calm, and other apps, plus devices like CalmiGo and aromatherapy mists. Prices and features are provided for each product.